Where Does CLVS Stock Rank in the Biotechnology Industry? – InvestorsObserver

Clovis Oncology Inc (CLVS) is near the top in its industry group according to InvestorsObserver. CLVS gets an overall rating of 60. That means it scores higher than 60 percent of stocks. Clovis Oncology Inc gets a 79 rank in the Biotechnology industry. Biotechnology is number 84 out of 148 industries.

Click Here to get the full Stock Score Report on Clovis Oncology Inc (CLVS) Stock.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Clovis Oncology Inc (CLVS) stock is up 14.18% while the S&P 500 is down -0.23% as of 11:06 AM on Friday, Nov 29. CLVS has gained $1.76 from the previous closing price of $12.41 on volume of 16,936,555 shares. Over the past year the S&P 500 has risen 14.93% while CLVS is down -17.62%. CLVS lost -$7.51 per share the over the last 12 months.

To see the top 5 stocks in Biotechnology click here.

See the original post:
Where Does CLVS Stock Rank in the Biotechnology Industry? - InvestorsObserver